Cut GLP-1 costs in half. Without cutting access
Embla pairs GLP-1s with behavioral coaching so employees need less medication to lose more weight. The result: better outcomes, lower pharmacy spend, and a benefit your plan can sustain.
GLP-1 pressure is growing fast
Why most GLP-1
coverage backfires
High-dose prescriptions with no controls overwhelm self-funded budgets.
No coaching means poor adherence, low impact, and inevitable weight regain.
When behavior doesn’t change, medication alone doesn’t last.
Embla is a better way to offer GLP-1s
We combine low-dose GLP-1s, 1:1 behavioral coaching, and structured tapering to deliver long-term weight loss at a fraction of the cost — with no admin burden for your team.
Boosted engagement
Employees connect with 1:1 coaches, log progress in-app, and stay motivated through expert support.
Measurable health gains
From weight loss to mental resilience — our coaching improves the whole person, not just the number on the scale.
Controlled costs
We keep members in lower GLP-1 tiers and taper early, saving $4,800–$7,800 per employee annually.
Better performance
Healthier employees miss fewer days, perform better, and feel more confident at work.
Our programs
Metabolic care built around behavior change, medication when needed, and long-term support.
Behavior-first metabolic care
GLP-1 + behavior change
Weight maintenance support
Launch in weeks. Fully managed.
Getting started with Embla is fast and seamless. We handle everything so you don’t have to.
01. Connect with us
We’ll schedule your launch data and get aligned on goals and participants.
02. We take care of setup
Our team handles onboarding, communications, and custom roll out materials. No integration or extra work on your end.
03. Start changing lives
Our program is up and running in within 1-2 weeks. We’ll keep you updated on engagement, results, and health improvements.
Proven in the real world
The TRIM study validates our treat-to-target model. With the right coaching support, 2,694 participants lost an average of 16.7% of their body weight — using less than half the typical semaglutide dose.
Real-world results,
Real-world savings
We keep employees on the lowest effective dose — saving thousands per person.
Outperforms GLP-1s alone by 40–85%.
Lower A1c, cholesterol, blood pressure, inflammation — and fewer obesity-related claims.
Ready to take control
of GLP-1 spend?
Let’s talk about how Embla can reduce costs and improve health outcomes for your workforce.